Status:
COMPLETED
A Combination HIV Prevention Strategy for Young Women at Risk for HIV
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to conduct formative research to inform the design and implementation of combination prevention interventions, including pre-exposure prophylaxis (PrEP) for female sex wor...
Detailed Description
Despite remarkable advances in the global HIV response with 17 million persons, out of nearly 37 million living with HIV, who have initiated antiretroviral therapy (ART) in low- and middle-income coun...
Eligibility Criteria
Inclusion
- FSW. Inclusion criteria for the structured interviews, FGDs and IDI are identical.
- Report being female or transgender women born make who have sex with men
- Report being HIV-negative or unknown status
- Report being between 18-24 years of age
- Report residing or working in study community
- Reports exchange sex for goods, money, flavors or other services in past 3 months
- Willing to allow audio-recording of FGDs or IDI
- Able to complete study procedures in English, Kiswahili or Dhuluo
- Male Clients
- Male
- Report being \>=18 years of age
- Report exchanging goods, money, favors or other services for sex in past 3 months
- Willing to allow audio-recording of IDI
- Able to complete study procedures in English, Kiswahili or Dhuluo
- Health Care Providers
- Currently working as nurse or clinical officer at a clinic or other facility likely to offer PrEP
- Report being \>= 18 years of age
- Willing to allow audio-recording of IDI
- Able to complete study procedures in English
Exclusion
- Individuals who do not meet the inclusion criteria
- Individuals who in the opinion of the investigators would interfere with adherence to study study requirements
- FSW participating in FGD are not eligible for participation in IDI
Key Trial Info
Start Date :
June 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2018
Estimated Enrollment :
329 Patients enrolled
Trial Details
Trial ID
NCT03235518
Start Date
June 28 2017
End Date
April 4 2018
Last Update
January 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kisumu, Kenya
Kisumu, Kenya